AbbVie's HIV drug Kaletra stumbles in COVID-19 trial, but one analyst begs to differ

Press/Media

Period19 Mar 2020

Media coverage

1

Media coverage

  • TitleAbbVie's HIV drug Kaletra stumbles in COVID-19 trial, but one analyst begs to differ
    Media name/outletFiercePharma Pharma Asia
    CountryUnited States
    Date19/03/20
    PersonsEric J. Rubin, Lindsey R. Baden